Affiliation:
1. Omsk State Medical University
Abstract
Nonalcoholic fatty liver disease (NAFLD) makes a major impact on morbidity and mortality among the workingage population in developed countries. In the lack of effective pharmacological methods, the leading role in treatment of NAFLD belongs to lifestyle modification, consistent and gradual weight loss, and its maintenance. The qualitative and quantitative structure of the diet, intensity of physical activity, and most importantly, regularity and consistency of implementation of lifestyle modification activities are the key to successful management of patients with NAFLD.To date, there are very few studies on adherence to lifestyle modification activities in this group of patients, which is mainly due to a deficiency of methodological tools. The questionnaire “QAA-25” recommended by the Russian Scientific Medical Society of Therapists for quantitative assessment of adherence to treatment allows to assess both adherence to therapy in general and adherence to its individual components (adherence to drug therapy, adherence to medical counseling, and adherence to lifestyle modification), which requires further study taking into account features of therapeutic strategies in treating NAFLD.
Publisher
Siberian State Medical University
Reference79 articles.
1. Byrne C.D., Targher G. NAFLD: A multisystem disease. Journal of Hepatology. 2015; 61 (Suppl. 1): 47–64. DOI: 10.1016/j.jhep.2014.12.012.
2. Livzan M.A., Lapteva I.V., Miller T.S. Rol' leptina i leptinorezistentnosti v formirovanii nealkogol'noi zhirovoi bolezni pecheni u lits s ozhireniem i izbytochnoi massoi tela. Eksperimental'nya i klinicheskaya gastroenterologiya. 2014; 108 (8): 27–33.
3. Rodriguez B., Torres D.M., Harrison S.A. Physical activity: An essential component of lifestyle modification in NAFLD. Nature Reviews Gastroenterology and Hepatology. 2012; 9 (12): 726–731. DOI: 10.1038/nrgastro.2012.200.
4. Bedogni G., Nobili V., Tiribelli C. Epidemiology of fatty liver: An update. World Journal of Gastroenterology. 2014; 20 (27): 9050–9054. DOI: 10.3748/wjg.v20.i27.9050.
5. Pappachan J.M., Babu S., Krishnan B., Ravindran N.C. Non-alcoholic fatty liver disease: a clinical update. J. Clin. Transl. Hepatol. 2017; 5 (4): 384–393. DOI: 10.14218/jcth.2017.00013.